XML 38 R31.htm IDEA: XBRL DOCUMENT v3.25.2
Employee Benefit Plans (Tables)
6 Months Ended
Jun. 29, 2025
Employee Benefit and Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Stock Option Activity

Stock option activity was as follows:

 

(In thousands, except per share amounts)

 

Number of
Shares

 

 

Weighted Average Exercise Price Per Share

 

Outstanding as of December 31, 2024

 

 

475

 

 

$

32.60

 

Exercised

 

 

(198

)

 

$

26.56

 

Expired

 

 

(170

)

 

$

38.97

 

Outstanding as of June 29, 2025

 

 

107

 

 

$

33.73

 

Schedule of Time-Based RSU Activity

Time-based RSU activity was as follows:

 

(In thousands, except per share amounts)

 

Number
of Shares

 

 

Weighted Average Grant Date Fair Value Per Share

 

Outstanding as of December 31, 2024

 

 

2,550

 

 

$

17.64

 

Granted

 

 

548

 

 

$

28.19

 

Vested

 

 

(765

)

 

$

17.91

 

Cancelled

 

 

(127

)

 

$

18.34

 

Outstanding as of June 29, 2025

 

 

2,206

 

 

$

20.12

 

Schedule of PSU Activity

PSU activity was as follows:

(In thousands, except per share amounts)

 

Number
of Shares

 

 

Weighted Average Grant Date Fair Value Per Share

 

Outstanding as of December 31, 2024

 

 

655

 

 

$

20.93

 

Granted

 

 

374

 

 

$

47.13

 

Vested

 

 

(249

)

 

$

20.85

 

Cancelled

 

 

(31

)

 

$

19.80

 

Outstanding as of June 29, 2025

 

 

749

 

 

$

34.10

 

Schedule of Total Stock-Based Compensation Expense Resulting from Stock Options, RSUs, Time-Based and Performance-Based and the ESPP

Valuation and Expense Information

 

The following table sets forth the stock-based compensation expense resulting from stock options, RSUs (time-based and performance-based) and the ESPP included in the Company’s unaudited condensed consolidated statements of operations:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

(In thousands)

 

June 29, 2025

 

 

June 30, 2024

 

 

June 29, 2025

 

 

June 30, 2024

 

Cost of revenue

 

$

456

 

 

$

413

 

 

$

878

 

 

$

778

 

Research and development

 

 

1,000

 

 

 

844

 

 

 

1,592

 

 

 

1,542

 

Sales and marketing

 

 

1,816

 

 

 

1,235

 

 

 

3,129

 

 

 

2,472

 

General and administrative

 

 

3,403

 

 

 

3,396

 

 

 

6,572

 

 

 

5,640

 

Total

 

$

6,675

 

 

$

5,888

 

 

$

12,171

 

 

$

10,432